As the Chief Quality Officer Jackie is responsible for providing quality and compliance oversight of the company’s regulated activities in research and development, global manufacturing and supply of products worldwide.
She joined BMS in 2017 from Merck, where she was Senior Vice President of Global Quality. Jackie’s responsibilities included global quality oversight of new product development and commercialization of pharmaceutical, vaccine and biological products, as well as Merck’s global manufacturing network in support of their human and animal health business.
Jackie moved to the U.S. in 2001 from England when she joined Schering-Plough to lead analytical science activities for their respiratory development programs. In 2004, she transitioned into the Quality function and was named Vice President of Pharmaceutical Sciences Quality. In this role, she led the consent decree activities for the Schering-Plough Research Institute until the decree’s dissolution in 2007. She was then appointed Vice President of Global Research Quality for the entire Schering-Plough Research Institute. In 2009, Schering-Plough merged with Merck and Jackie was appointed as Vice President of Research & Commercialization Quality. Her responsibilities later expanded to include Global CMC Regulatory Affairs as well as Quality Operations for the Americas, Asia Pacific and the Consumer Care business.
Jackie began her career at Fisons PLC as an analytical chemist and then took on varying roles of increasing responsibility and leadership within analytical sciences within Rhone-Poulenc Rorer and Aventis prior to joining Schering-Plough. Jackie holds a Joint Honors Bachelor’s Degree in Chemistry and Pharmacology, and a PhD in Organic Chemistry, both from the University of Liverpool, England.